Arovella Therapeutics Ltd banner

Arovella Therapeutics Ltd
ASX:ALA

Watchlist Manager
Arovella Therapeutics Ltd Logo
Arovella Therapeutics Ltd
ASX:ALA
Watchlist
Price: 0.08 AUD 2.56% Market Closed
Market Cap: AU$96.1m

Profitability Summary

Arovella Therapeutics Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Arovella Therapeutics Ltd

Margins Comparison
Arovella Therapeutics Ltd Competitors

Country Company Market Cap Operating
Margin
Net
Margin
AU
Arovella Therapeutics Ltd
ASX:ALA
96.1m AUD
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
951.3B USD
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
595.7B USD
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
289.1B CHF
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
246.1B CHF
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
234.1B GBP
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
297.5B USD
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
151.6B USD
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
124.5B USD
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Arovella Therapeutics Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
AU
Arovella Therapeutics Ltd
ASX:ALA
96.1m AUD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
951.3B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
595.7B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
289.1B CHF
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
246.1B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
234.1B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
297.5B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
151.6B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
124.5B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Arovella Therapeutics Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett